Inify Laboratories AB (INIFY)
XOSL 
XFRA Primary XOSL Summary
Inify Laboratories AB (INIFY) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Inify Laboratories AB ever had a stock split?
Inify Laboratories AB Profile
| Professional Services Industry | Industrials Sector | Mr. Fredrik Palm CEO | XOSL Exchange | SE0017486103 ISIN |
| Sweden Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
INIFY Laboratories AB is a pioneering medical diagnostic company based in Stockholm, Sweden, specializing in cancer diagnostics. Established in 2021, this innovative firm focuses on the critical area of cancer detection, aiming to revolutionize the approach towards diagnosis and early detection. Specifically, INIFY Laboratories AB dedicates its resources to addressing the growing need for accurate and timely diagnostics in the battle against prostate cancer, one of the most common cancers affecting men globally. Through its advanced diagnostic services, the company strives to make a significant impact on patient outcomes by enabling earlier intervention strategies.
Products and Services
-
Prostate Cancer Diagnostics Services
INIFY Laboratories AB offers specialized diagnostics services aimed at the early detection and accurate diagnosis of prostate cancer. Utilizing cutting-edge technology and pioneering diagnostic methodologies, the company is dedicated to improving the precision of prostate cancer screening. This service is crucial for timely intervention and personalized treatment planning, thus significantly enhancing the survival rates and quality of life for patients.
